Takeda Pharmaceutical
TAK
S$18.44
Share price
0.07%
Change (1 day)
0.29%
Change (1 year)
Categories
Takeda Pharmaceutical (TAK) - Total assets
Total assets on the balance sheet as of March 2025 : S$122.37 Billion
According to Takeda Pharmaceutical's latest financial reports the company's total assets are S$122.37 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Takeda Pharmaceutical - Total assets on balance sheet (from 2008 to 2025)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-03-31 | S$134.49 B | -3.38% |
| 2023-03-31 | S$139.20 B | -5.03% |
| 2022-03-31 | S$146.57 B | -6.53% |
| 2021-03-31 | S$156.81 B | -7.51% |
| 2020-03-31 | S$169.54 B | 0.75% |
| 2019-03-31 | S$168.28 B | 232.26% |
| 2018-03-31 | S$50.64 B | -7.17% |
| 2017-03-31 | S$54.55 B | 19.02% |
| 2016-03-31 | S$45.83 B | -6.75% |
| 2015-03-31 | S$49.15 B | -11.76% |
| 2014-03-31 | S$55.70 B | 4.43% |
| 2013-03-31 | S$53.34 B | -2.46% |
| 2012-03-31 | S$54.68 B | 29.84% |
| 2011-03-31 | S$42.12 B | 0.2% |
| 2010-03-31 | S$42.03 B | -1.09% |
| 2009-03-31 | S$42.49 B | 10.62% |
| 2008-03-31 | S$38.41 B | -2.95% |
| 2007-03-31 | S$39.58 B | -5.82% |
| 2006-03-31 | S$42.02 B | 7.19% |
| 2005-03-31 | S$39.21 B | 4.24% |
| 2004-03-31 | S$37.61 B | 21.84% |
| 2003-03-31 | S$30.87 B | 13.43% |
| 2002-03-31 | S$27.21 B | 8.64% |
| 2001-03-31 | S$25.05 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | S$249.36 B | 103.77% | 🇺🇸 USA |
 Sanofi SNY | S$183.72 B | 50.13% | 🇫🇷 France |
 Pfizer PFE | S$267.84 B | 118.88% | 🇺🇸 USA |
 Novartis NVS | S$128.67 B | 5.15% | 🇨🇭 Switzerland |
 Seagen
SGEN | S$4.67 B | -96.18% | 🇺🇸 USA |
 Dr. Reddy's Laboratories RDY | S$7.42 B | -93.93% | 🇮🇳 India |
 Amgen AMGN | S$115.06 B | -5.97% | 🇺🇸 USA |
 GlaxoSmithKline GSK | S$100.99 B | -17.47% | 🇬🇧 UK |
 Merck MRK | S$148.22 B | 21.12% | 🇺🇸 USA |